Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pinostilbene is a naturally occurring monomethylated analog of resveratrol, a polyphenol found in grapes and other plants. It is being investigated for its potential antineoplastic properties, particularly in the context of advanced prostate cancer. Research indicates that pinostilbene can inhibit the viability, proliferation, and metastatic potential of prostate cancer cells, showing significantly higher potency in more invasive cell lines compared to less invasive ones. As a derivative of resveratrol, it shares structural similarities but may offer improved bioavailability or specific activity profiles that make it a candidate for the management of lethal prostate cancer stages.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pinostilbene.